Bristol-Myers Squibb Company (BMY) Insider Trading
- $16,028,814.61
- $516,752,485.91
- Dec. 5, 2023
- Lamberto Andreotti
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 27, 2014 | Director | 100,000 | $102.85 | Sell | $10,285,000.00 | |
| Oct. 24, 2014 | Director | 15,000 | $102.94 | Sell | $1,544,100.00 | |
| Oct. 24, 2014 | CEO | 50,000 | $53.00 | Sell | $2,650,000.00 | |
| Oct. 6, 2014 | CEO | 50,000 | $50.99 | Sell | $2,549,500.00 | |
| Sept. 16, 2014 | EVP | 63,667 | $50.77 | Sell | $3,232,373.59 | |
| Sept. 15, 2014 | COO | 26,691 | $49.87 | Sell | $1,331,080.17 | |
| Sept. 10, 2014 | SVP | 7,415 | $51.03 | Sell | $378,387.45 | |
| Sept. 8, 2014 | CEO | 50,000 | $51.05 | Sell | $2,552,500.00 | |
| Sept. 8, 2014 | Director | 30,000 | $93.73 | Sell | $2,811,900.00 | |
| Aug. 19, 2014 | SVP | 20,000 | $49.89 | Sell | $997,800.00 | |
| Aug. 4, 2014 | Insider | 39,104 | $87.55 | Sell | $3,423,555.20 | |
| July 29, 2014 | CFO | 67,621 | $51.06 | Sell | $3,452,728.26 | |
| July 28, 2014 | SVP | 25,752 | $49.32 | Sell | $1,270,088.64 | |
| July 25, 2014 | Director | 17,600 | $87.03 | Sell | $1,531,728.00 | |
| May 1, 2014 | Insider | 11,922 | $146.78 | Sell | $1,749,911.16 | |
| March 13, 2014 | SVP | 9,137 | $55.20 | Sell | $504,362.40 | |
| March 10, 2014 | Insider | 8,799 | $55.81 | Sell | $491,072.19 | |
| March 10, 2014 | CEO | 100,000 | $55.52 | Sell | $5,552,000.00 | |
| March 5, 2014 | Director | 100,000 | $55.82 | Sell | $5,582,000.00 | |
| March 4, 2014 | Director | 12,770 | $162.33 | Sell | $2,072,954.10 | |
| Feb. 28, 2014 | Insider | 6,088 | $54.49 | Sell | $331,735.12 | |
| Feb. 24, 2014 | EVP | 41,563 | $54.44 | Sell | $2,262,689.72 | |
| Feb. 19, 2014 | SVP | 9,534 | $54.22 | Sell | $516,933.48 | |
| Feb. 18, 2014 | EVP | 29,800 | $54.61 | Sell | $1,627,378.00 | |
| Feb. 14, 2014 | CFO | 52,963 | $54.35 | Sell | $2,878,539.05 | |
| Feb. 14, 2014 | General Counsel | 10,490 | $54.28 | Sell | $569,397.20 | |
| Feb. 11, 2014 | CEO | 86,075 | $52.66 | Sell | $4,532,709.50 | |
| Feb. 6, 2014 | SVP | 35,471 | $48.90 | Sell | $1,734,531.90 | |
| Feb. 5, 2014 | Director | 2,500 | $48.28 | Sell | $120,700.00 | |
| Feb. 5, 2014 | Director | 13,500 | $151.87 | Sell | $2,050,245.00 | |
| Feb. 4, 2014 | Director | 100,000 | $48.90 | Sell | $4,890,000.00 | |
| Dec. 23, 2013 | Insider | 12,062 | $168.19 | Sell | $2,028,707.78 | |
| Oct. 25, 2013 | Director | 18,750 | $157.67 | Sell | $2,956,312.50 | |
| Sept. 4, 2013 | Director | 15,000 | $143.92 | Sell | $2,158,800.00 | |
| Aug. 28, 2013 | Insider | 32,263 | $137.06 | Sell | $4,421,966.78 | |
| Aug. 2, 2013 | Insider | 93,008 | $146.50 | Sell | $13,625,672.00 | |
| July 29, 2013 | Director | 5,000 | $43.81 | Sell | $219,050.00 | |
| June 10, 2013 | SVP | 25,000 | $47.24 | Sell | $1,181,000.00 | |
| June 6, 2013 | SVP | 26,275 | $46.53 | Sell | $1,222,575.75 | |
| June 5, 2013 | SVP | 25,997 | $46.33 | Sell | $1,204,441.01 | |
| June 4, 2013 | CEO | 100,000 | $47.74 | Sell | $4,774,000.00 | |
| June 4, 2013 | SVP | 58,898 | $47.38 | Sell | $2,790,587.24 | |
| June 3, 2013 | EVP | 83,647 | $48.18 | Sell | $4,030,112.46 | |
| May 31, 2013 | Insider | 10,538 | $47.06 | Sell | $495,918.28 | |
| May 31, 2013 | EVP | 91,282 | $47.00 | Sell | $4,290,254.00 | |
| May 30, 2013 | EVP | 22,000 | $47.00 | Sell | $1,034,000.00 | |
| May 30, 2013 | Insider | 68,087 | $123.58 | Sell | $8,414,191.46 | |
| May 29, 2013 | Director | 1,000 | $123.72 | Buy | $123,720.00 | |
| May 28, 2013 | Insider | 32,959 | $124.91 | Sell | $4,116,908.69 | |
| May 28, 2013 | CFO | 25,000 | $48.68 | Sell | $1,217,000.00 |
Insiders are both buying and selling Bristol-Myers Squibb Company stock.
The insider traders at Bristol-Myers Squibb Company are: Lamberto Andreotti, Giovanni Caforio, Gilla Kaplan, James M Cornelius, Ernest Mario, Sandra Leung, Rupert Vessey, Joseph C Caldarella, James J Loughlin, Michael D Casey, Louis S Schmukler, Autenried Paul Von, Theodore R Samuels II, John E Elicker, Robert J Hugin, Ann Powell, Samuel J Moed, Adam Dubow, Beatrice J Cazala, Charles A Bancroft, Christopher S Boerner, Mark J Alles, Michael A Friedman, Joseph Caldarella, James Cornelius, Joseph Eid, Karen Murphy Santiago, Francis M Cuss, Lewis B Campbell, Louis Schmukler, Thomas O Daniel, Michael D. Casey, Perry A Karsen, Richard W Barker, Dinesh C Paliwal, David V Elkins, Terrie Curran, Elliot Sigal, Charles Bancroft, Michael W Bonney, John H Weiland, Perry Karsen, Carrie Smith Cox, Robert J Bertolini, Thomas Daniel, Lawrence Stein, Lawrence V Stein, Robert M Plenge, Lewis Campbell, John Elicker, Francis Cuss, Thomas J Jr. Lynch, Corp /De/ Celgene, and Michael Casey
The most active insider trader at Bristol-Myers Squibb Company is Lamberto Andreotti with 27 trades.
Robert J Hugin has sold the most Bristol-Myers Squibb Company stock with a total value of $90,990,863.06.
Corp /De/ Celgene has bought the most Bristol-Myers Squibb Company stock with a total value of $22,404,200.00.
The most recent insider trade for Bristol-Myers Squibb Company was on Dec. 5, 2023.
The single biggest insider buy for Bristol-Myers Squibb Company was from Corp /De/ Celgene with a total value of $11,202,100.00 on Oct. 24, 2016.
The single biggest insider sell for Bristol-Myers Squibb Company was from Robert J Hugin with a total value of $23,604,615.80 on June 22, 2017.